Jump to:
loading...| Preferred Name |
aptiganel |
| Synonyms |
aptiganel hydrochloride |
| ID |
http://purl.bioontology.org/ontology/MESH/C079779 |
| altLabel |
aptiganel hydrochloride CNS 1102 CNS-1102 CERESTAT N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine HCl |
| cui |
C0213555 C0950847 C0527539 C0527540 |
| HM |
D006146 |
| Inverse of RB |
40PWH14OXW 46475LV84I |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19930320 |
| MeSH Frequency |
34 |
| MMR |
20141031 |
| notation |
C079779 |
| PA |
D018696 D018691 |
| prefLabel |
aptiganel |
| RR |
40PWH14OXW 137159-92-3 (aptiganel) |
| SC |
1 |
| Scope Statement |
NMDA receptor antagonist used to study the effects of stroke; structure given in first source; RN given refers to hydrochloride |
| SRC |
Neurology 1993 Feb;43(2):397-403 |
| TERMUI |
T243458 T243459 T243457 T243455 T243456 T243454 |
| TH |
FDA SRS (2015) NLM (1993) FDA SRS (2013) USAN (19XX) USAN (1996) INN (19XX) |
| tui |
T109 T121 |